Generating Robust Clinical Trial Data with the nCounter Analysis System


Our first session is dedicated to direct detection gene expression analysis with the nCounter platform. Join NanoString and subject matter experts from academia and CROs as we discuss how nCounter panel content and gene expression profiling (GEP) signatures can be used to accelerate drug discovery and development:

  • nCounter Analysis System technology overview
  • Scientific presentation
  • Spotlight CRO presentations highlighting validation studies, performance data and capability offerings


nCounter IntroductionMaxine McClain, PhD
Targeted gene expression profiling predicts meningioma outcomes and radiotherapy responsesWilliam Chen, M.D.
nCounter IO 360 Validation & Services OfferedJames Cox, MS
From Pre-Clinical to Clinical: Life of an nCounter study at Propath UKJoana Campos, PhD

Register Now


Maxine McClain, PhD

Field Applications Scientist Senior Manager, NanoString Technologies

James Cox, MS

Scientist, Research & Development, Eurofins

William Chen, M.D.

Clinical Instructor, Department of Radiation Oncology, University of California, San Francisco

Joana Campos

Senior Study Manager, Propath UK